Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
FibroGen ( (FGEN) ) has shared an announcement.
Suzanne Blaug, Benjamin Cravatt, and Gerald Lema have resigned from the Board of Directors of FibroGen, Inc., effective September 30, 2024, with no disagreements cited regarding company operations, policies, or practices. Their valuable contributions in various committee roles since joining the company have been recognized and appreciated. Following their departure, FibroGen has announced new appointments to the Audit, Compensation, and Nominating and Corporate Governance Committees, ensuring a smooth transition and continued governance oversight.
Find detailed analytics on FGEN stock on TipRanks’ Stock Analysis page.
